Up-regulation of slow K+ channels in peripheral motor axons: A transcriptional channelopathy in multiple sclerosis

Brain

Volumn 131, Issue 11, 2008, Pages 3062-3071

  Ng, Karl ^a,b   Howells, James ^a   Pollard, John D ^a   Burke, David ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Channelopathy; Motoneuron; Multiple sclerosis; Plasticity; Slow K channel

Indexed keywords

POTASSIUM CHANNEL;

ADULT; ARTICLE; CHANNELOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; MEDIAN NERVE; MEMBRANE POTENTIAL; MULTIPLE SCLEROSIS; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; PERIPHERAL NERVE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD MOTONEURON; UPREGULATION;

ADULT; AXONS; FEMALE; HUMANS; MALE; MEDIAN NERVE; MEMBRANE POTENTIALS; MIDDLE AGED; MODELS, NEUROLOGICAL; MOTOR NEURONS; MULTIPLE SCLEROSIS; NEURAL CONDUCTION; NEURONAL PLASTICITY; POTASSIUM CHANNELS; UP-REGULATION;

EID: 55749094503     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn180     Document Type: Article

References (53)

1. Antonini G, Millefiorini E, Borsellino G, Morino S, Rasura M, Pozzilli C. Subclinical peripheral nervous system involvement in multiple sclerosis. Muscle Nerve 1995; 18: 1216-7.
2. Boërio D, Créange A, Hogrel JY, Lefaucheur JP. Alteration of motor nerve recovery cycle in multiple sclerosis. Clin Neurophysiol 2007; 118: 1753-8.
3. Bostock H. MEMFIT: a computer program to aid interpretation of multiple excitability measurements on human motor axons. Clin Neurophysiol 2006; 117: S85-6.
4. Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 1991; 441: 537-57.
5. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58.
6. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol 1997; 498: 277-94.
7. Burke D, Adams RW, Skuse F. The effects of voluntary contraction on the H reflex of human limb muscles. Brain 1989; 112: 417-33.
8. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001; 112: 1575-85.
9. Button DC, Kalmar JM, Gardiner K, Marqueste T, Zhong H, Roy RR, et al. Does elimination of afferent input modify the changes in rat motoneurone properties that occur following chronic spinal cord transection? J Physiol 2008; 586: 529-44.
10. Cappelen-Smith C, Kuwabara S, Lin CS-Y, Mogyoros I, Burke D. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain 2001; 124: 2439-47.
11. Dib-Hajj SD, Fjell J, Cummins TR, Zheng Z, Fried K, LaMotte R, et al. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 1999; 83: 591-600.
12. Eisen A, Paty D, Hoirch M. Altered supernormality in multiple sclerosis peripheral nerve. Muscle Nerve 1982; 5: 411-4.
13. Gardiner P, Dai Y, Heckman CJ. Effects of exercise training on alpha-motoneurons. J Appl Physiol 2006; 101: 1228-36.
14. Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG. Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004; 24: 4832-9.
15. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002; 125: 1887-95.
16. Hasson J, Terry RD, Zimmerman HM. Peripheral neuropathy in multiple sclerosis. Neurology 1958; 8: 503-10.
17. Heckman CJ, Gorassini MA, Bennett DJ. Persistent inward currents in motoneuron dendrites: implications for motor output. Muscle Nerve 2005; 31: 135-56.
18. Heckman CJ, Hyngstrom AS, Johnson MD. Active properties of motoneurone dendrites: diffuse descending neuromodulation, focused local inhibition. J Physiol 2008; 586: 1225-31.
19. Hopf HC, Eysholdt M. Impaired refractory periods of peripheral sensory nerves in multiple sclerosis. Ann Neurol 1978; 4: 499-501.
20. Hultborn H. Spinal reflexes, mechanisms and concepts: from Eccles to Lundberg and beyond. Prog Neurobiol 2006; 78: 215-32.
21. Hultborn H, Malmsten J. Changes in segmental reflexes following chronic spinal cord hemisection in the cat. II. Conditioned monosynaptic test reflexes. Acta Physiol Scandinav 1983; 119: 423-33.
22. Jankelowitz SK, Howells J, Burke D. Plasticity of inwardly rectifying conductances following a corticospinal lesion in human subjects. J Physiol 2007a; 581: 927-40.
23. Jankelowitz SK, McNulty PA, Burke D. Changes in measures of motor axon excitability with age. Clin Neurophysiol 2007b; 118: 1397-404.
24. Johnson EW, Denny S. Kelley JP. Sequence of electromyographic abnormalities in stroke syndrome. Arch Phys Med Rehabil 1975; 56: 468-73.
25. Judge SI, Bever CT Jr. Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther 2006; 111: 224-59.
26. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006; 129: 953-62.
27. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123: 2542-51.
28. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409.
29. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001; 70: 56-64.
30. Kiernan MC, Isbister GK, Lin CS-Y, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005; 57: 339-48.
31. Kocsis JD, Bowe CM, Waxman SG. Different effects of 4-aminopyridine on sensory and motor fibers: pathogenesis of paresthesias. Neurology 1986; 36: 117-20.
32. Kocsis JD, Ruiz JA, Waxman SG. Maturation of mammalian myelinated fibers: changes in action-potential characteristics following 4-aminopyridine application. J Neurophysiol 1983; 50: 449-63.
33. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
34. Lassmann H, Budka H, Schnaberth G. Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol 1981; 38: 99-102.
35. Li Y, Gorassini MA, Bennett J. Role of persistent sodium and calcium currents in motoneuron firing and spasticity in chronic spinal rats. J Neurophysiol 2004; 91: 767-83.
36. Lin CS-Y, Kiernan MC, Burke D, Bostock H. Assessment of nerve excitability properties in peripheral nerve disease. In: Kimura J, vol. editor. Daube JR, Mauguière F, series editors. Handbook of Clinical Neurophysiology. Vol. 7, Peripheral Nerve Diseases. Amsterdam: Elsevier; 2006. p. 381-403.
37. Lin CS-Y, Macefield VG, Elam M, Wallin BG, Engel S, Kiernan MC. Axonal changes in spinal cord injured patients distal to the site of injury. Brain 2007; 130: 985-94.
38. Mathey EK, Derfuss T, Storch MK, Williams KR, Hales K, Woolley DR, et al. Neurofascin as a novel target for autoantibody-mediated axonal injury. J Exp Med 2007; 204: 2363-72.
39. Meulstree J, Darbas A, van Doorn PA, van Briemen L, van der Meche FG. Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies. J Neurol Neurosurg Psychiatry 1997; 62: 398-400.
40. Miglietta O, Lowenthal M. A study of peripheral nerve involvement in fifty-four patients with multiple sclerosis. Arch Phys Med Rehabil 1961; 42: 573-578.
41. Pollock M, Calder C, Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann Neurol 1977; 2: 41-8.
42. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-6.
43. Ro YI, Alexander CB, Oh SJ. Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy. Muscle Nerve 1983; 6: 312-6.
44. Schoene WC, Carpenter S, Behan PO, Geschwind N. 'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain 1977; 100: 755-73.
45. + current regulating excitability in the rat node of Ranvier. J Physiol 2006; 573: 17-34.
46. Shefner JM, Carter JL, Krarup C. Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve 1992; 15: 73-6.
47. Spaans F, Wilts G. Denervation due to lesions of the central nervous system. An EMG study in cases of cerebral contusion and cerebrovascular accidents. J Neurol Sci 1982; 57: 291-305.
48. Sung JY, Kuwabara S, Kaji R, Ogawara K, Mori M, Kanai K, et al. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Muscle Nerve 2004; 29: 28-37.
49. Waxman SG. Peripheral nerve abnormalities in multiple sclerosis. Muscle Nerve 1993; 16: 1-5.
50. Waxman SG. Transcriptional channelopathies: an emerging class of disorders. Nat Rev Neurosci 2001; 2: 652-9.
51. Weiss G. Sur la possibilité de rendre comparables entre eux les appareils servant à l'excitation électrique. Arch Ital Biol 1901; 35: 413-6.
52. Wolpaw J, Tennissen AM. Activity-dependent spinal cord plasticity in health and disease. Annu Rev Neurosci 2001; 24: 807-43.
53. Zhao P, Waxman SG, Hains BC. Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Mol Pain 2006; 2: 27.